|
Volumn 52, Issue 5, 2008, Pages 325-328
|
Development of clevudine resistance after switching from lamivudine in a patient with chronic hepatitis B
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
2'-FLUORO-5-METHYLARABINOSYLURACIL;
ADEFOVIR;
ADENINE;
ANTIVIRUS AGENT;
CLEVUDINE;
DRUG DERIVATIVE;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
PHOSPHONIC ACID DERIVATIVE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
UNCLASSIFIED DRUG;
URACIL ARABINOSIDE;
VIRUS DNA;
ADULT;
AMINO ACID SUBSTITUTION;
ARTICLE;
BLOOD;
CASE REPORT;
GENETICS;
HEPATITIS B;
HUMAN;
MALE;
METABOLISM;
MULTIDRUG RESISTANCE;
NUCLEOTIDE SEQUENCE;
ADENINE;
ADULT;
AMINO ACID SUBSTITUTION;
ANTIVIRAL AGENTS;
ARABINOFURANOSYLURACIL;
BASE SEQUENCE;
DNA, VIRAL;
DRUG RESISTANCE, MULTIPLE, VIRAL;
HEPATITIS B E ANTIGENS;
HEPATITIS B, CHRONIC;
HUMANS;
LAMIVUDINE;
MALE;
PHOSPHONIC ACIDS;
REVERSE TRANSCRIPTASE INHIBITORS;
|
EID: 58149381284
PISSN: 15989992
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (0)
|